CSREA at 20 μg/mL significantly reduced DAGL-α expression relative to the RA group (p < 0.05), whereas the 40 μg/mL CSREA group showed a significant increase compared to the control group (p < 0.05). The gene discussed is DAGLA; the disease is rheumatoid arthritis.